| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Ann Thorac Surg 1990;49:440-444
© 1990 The Society of Thoracic Surgeons
Division of Cardiovascular Anesthesia, Texas Heart Institute, and University of Texas Health Science Center at Houston, Houston, Texas USA
Accepted for publication November 17, 1989.
* Address reprint requests to Dr Metz, Division of Cardiovascular Anesthesia, Texas Heart Institute, PO Box 20345, Houston, TX 77225-0345.
The activated coagulation time (ACT) is widely used to monitor adequacy of anticoagulation during cardiopulmonary bypass despite absence of data establishing an ACT below which adverse outcomes occur. For anticoagulation before Cardiopulmonary bypass, we administered a single dose of heparin (300 U/kg) to 193 patients and measured ACT and heparin levels at intervals after administration. No additional heparin was administered to any patient. Clot formation in the Cardiopulmonary bypass circuit and excessive postoperative chest tube drainage were considered outcomes indicating inadequate anticoagulation. Cardiopulmonary bypass averaged 59 ± 23 minutes (range, 30 to 138 minutes). Activated coagulation time values at every sampling period were normally distributed. In 51 patients (26.4%) ACT values were less than 400 seconds, including 4 less than 300 seconds, at some sampling time after heparinization. Patients with low ACT values did not bleed more postoperatively than those with high ACT values, nor was bleeding related to heparin level. No clots were found in any perfusion circuit. We conclude that a minimum ACT value for adequacy of heparinization is not yet defined but that it is less than 400 seconds.
This article has been cited by other articles:
|
|
 |
|
  J. H. Levy and R. M. Sniecinski Activated Clotting Times, Heparin Responses, and Antithrombin: Have We Been Wrong All These Years? Anesth. Analg., October 1, 2010; 111(4): 833 - 835. [Full Text] [PDF]
|
|
|
|
 |
|
 The Society of Thoracic Surgeons Blood Conservatio, V. A. Ferraris, S. P. Ferraris, S. P. Saha, E. A. Hessel II, C. K. Haan, B. D. Royston, C. R. Bridges, R. S.D. Higgins, G. Despotis, et al. Perioperative Blood Transfusion and Blood Conservation in Cardiac Surgery: The Society of Thoracic Surgeons and The Society of Cardiovascular Anesthesiologists Clinical Practice Guideline Ann. Thorac. Surg., May 1, 2007; 83(5_Supplement): S27 - S86. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. N. Shuhaibar, M. Hargrove, M. H. Millat, A. O'Donnell, and T. Aherne How much heparin do we really need to go on pump? A rethink of current practices Eur J Cardiothorac Surg, November 1, 2004; 26(5): 947 - 950. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. K. Neema, P. K. Sinha, and R. C. Rathod Activated Clotting Time During Cardiopulmonary Bypass: Is Repetition Necessary During Open Heart Surgery? Asian Cardiovasc Thorac Ann, March 1, 2004; 12(1): 47 - 52. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Shore-Lesserson Monitoring the Hematologic Complications of Cardiopulmonary Bypass Seminars in Cardiothoracic and Vascular Anesthesia, September 1, 2001; 5(3): 207 - 216. [Abstract] [PDF]
|
|
|
|
|
|
G. Leyvi, L. Shore-Lesserson, D. Harrington, F. Vela-Cantos, and S. Hossain An Investigation of a New Activated Clotting Time "MAX-ACT" in Patients Undergoing Extracorporeal Circulation Anesth. Analg., March 1, 2001; 92(3): 578 - 583. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H J Brinks, P W Weerwind, S Bogdan, H Verbruggen, and M H. Brouwer Does heparin pretreatment affect the haemostatic system during and after cardiopulmonary bypass? Perfusion, January 1, 2001; 16(1): 3 - 12. [Abstract] [PDF]
|
|
|
|
|
|
L. Shore-Lesserson, H. E. Manspeizer, M. Bolastig, D. Harrington, F. Vela-Cantos, and M. DePerio Anticoagulation for Cardiac Surgery in Patients Receiving Preoperative Heparin: Use of the High-Dose Thrombin Time Anesth. Analg., April 1, 2000; 90(4): 813 - 818. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. S. Weisinger and J. H. Levy Current Hematologic Issues in Cardiac Surgery and Cardiopulmonary Bypass Seminars in Cardiothoracic and Vascular Anesthesia, November 1, 1998; 2(4): 259 - 271. [Abstract] [PDF]
|
|
|
|
 |
|
 G. J. Despotis, J. H. Joist, and L. T. Goodnough Monitoring of hemostasis in cardiac surgical patients: impact of point-of-care testing on blood loss and transfusion outcomes Clin. Chem., September 1, 1997; 43(9): 1684 - 1696. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. J. Despotis, A. L. Alsoufiev, E. Spitznagel, L. T. Goodnough, and D. G. Lappas Response of Kaolin ACT to Heparin: Evaluation With an Automated Assay and Higher Heparin Doses Ann. Thorac. Surg., March 1, 1996; 61(3): 795 - 799. [Abstract] [Full Text]
|
|
|
|
 |
|
 G. J. Despotis, J. H. Joist, C. W. Hogue Jr., A. Alsoufiev, K. Kater, L. T. Goodnough, S. A. Santoro, E. Spitznagel, M. Rosenblum, and D. G. Lappas The impact of heparin concentration and activated clotting time monitoring on blood conservation: A prospective, randomized evaluation in patients undergoing cardiac operation J. Thorac. Cardiovasc. Surg., July 1, 1995; 110(1): 46 - 54. [Abstract] [Full Text]
|
|
|
|
 |
|
 R. Pifarre State-of-the-Art Review: Optimal Anticoagulation in Cardiovascular Surgery Clinical and Applied Thrombosis/Hemostasis, June 1, 1995; 1(3): 173 - 178. [Abstract] [PDF]
|
|
|
|
|
|
G. J. Despotis, A. L. Summerfield, J. H. Joist, L. T. Goodnough, S. A. Santoro, E. Spitznagel, J. L. Cox, and D. G. Lappas Comparison of activated coagulation time and whole blood heparin measurements with laboratory plasma anti-Xa heparin concentration in patients having cardiac operations J. Thorac. Cardiovasc. Surg., December 1, 1994; 108(6): 1076 - 1082. [Abstract] [Full Text]
|
|
|
|
|
|
K. Hashimoto, M. Yamagishi, T. Sasaki, M. Nakano, and H. Kurosawa Heparin and antithrombin III levels during cardiopulmonary bypass: Correlation with subclinical plasma coagulation Ann. Thorac. Surg., September 1, 1994; 58(3): 799 - 804. [Abstract] [PDF]
|
|
|
|
|
|
L. K. v. Segesser, B. M. Weiss, M. Pasic, E. Garcia, and M. I. Turina Risk and benefit of low systemic heparinization during open heart operations Ann. Thorac. Surg., August 1, 1994; 58(2): 391 - 398. [Abstract] [PDF]
|
|
|
|
|
|
M. J Hollingsed, R. C Hill, R. Wittig, G. F Murray, and E. H Stullken Heparin-coated cardiopulmonary bypass: a clinical case incorporating a standard cardiotomy Perfusion, October 1, 1992; 7(4): 305 - 314. [Abstract] [PDF]
|
|
|
|
|
|
E. A Hessel II Review article : What's new in monitoring the coronary surgery patient? Perfusion, July 1, 1992; 7(3): 161 - 194. [Abstract] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |
